Fintel reports that on February 20, 2025, Canaccord Genuity initiated coverage of Palvella Therapeutics (NasdaqCM:PVLA) with ...

Canaccord Genuity analyst Alexander Bedwany maintained a Buy rating on Taseko Mines (TGB – Research Report) today and set a price target of ...

Fintel reports that on February 19, 2025, Canaccord Genuity initiated coverage of Candel Therapeutics (NasdaqGM:CADL) with a ...

In a report released yesterday, Andrew Hodge from Canaccord Genuity maintained a Hold rating on ARB Corporation Limited (ARBFF – Research ...

SharkNinja (NYSE:SN – Free Report) had its price target increased by Canaccord Genuity Group from $129.00 to $136.00 in a ...

Supremex, Inc. showcases Q4 2024 growth with $2M annual savings from Toronto consolidation, 18.8% envelope EBITDA margins, and a strong 2025 outlook.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

We recently published a list of 15 Most Promising Technology Stocks to Buy Now. In this article, we are going to take a look ...

This article is published in Advanced Air Mobility part of Aviation Week Intelligence Network (AWIN), and is complimentary ...

CyberArk Software (NASDAQ:CYBR – Get Free Report) had its target price hoisted by equities research analysts at Canaccord ...

Canaccord Genuity has downgraded Pliant (PLRX) to hold following news that the company has paused a clinical trial for its ...

Aurora Innovation, Inc. (NASDAQ: AUR) today announced David Maday, Chief Financial Officer, will participate in a virtual ...